aetiolog
commun
acquir
pneumonia
vari
accord
region
acquir
review
discuss
caus
cap
occur
tropic
might
readili
recogniz
transplant
site
variou
form
pneumonia
includ
viral
caus
influenza
season
avian
varieti
coronavirus
hantaviru
well
bacteri
caus
specif
pneumon
form
yersinia
pesti
melioidosi
discuss
gener
commun
acquir
pneumonia
cap
caus
pathogen
common
geograph
area
pneumonia
virus
chlamydia
mycoplasma
legionella
less
commonli
aureu
k
pneumonia
howev
organ
endem
specif
region
earli
recognit
awar
critic
diagnosi
favour
outcom
less
case
resid
travel
tropic
region
review
discuss
preval
caus
potenti
lethal
infect
adult
respiratori
virus
account
cap
common
influenza
parainfluenza
adenoviru
respiratori
syncyti
virus
rsv
influenza
virus
classifi
core
protein
ie
b
c
belong
famili
orthomyxovirida
caus
predominantli
respiratori
diseas
human
influenza
type
b
account
n
viral
pneumonia
adult
wherea
influenza
c
infect
gener
caus
mild
respiratori
diseas
thought
caus
epidem
close
contact
human
anim
tropic
area
may
enhanc
genet
reassort
influenza
virus
dissemin
human
popul
may
result
pandem
import
respiratori
virus
tropic
caus
sever
pneumonia
influenza
avian
influenza
virus
sever
acut
respiratori
syndrom
associ
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
standard
droplet
contact
precaut
recommend
select
acut
respiratori
infect
whenev
possibl
patient
place
airborn
infect
isol
room
influenza
virus
associ
annual
epidem
intermitt
pandem
throughout
world
despit
absenc
winter
season
tropic
consist
season
infect
nevertheless
observ
composit
antigen
surfac
glycoprotein
influenza
viru
hemagglutinin
h
neuraminidas
n
use
subtyp
result
name
like
antigen
drift
repres
minor
chang
h
n
side
chain
respons
season
epidem
influenza
pandem
occur
less
frequent
result
major
chang
antigen
structur
envelop
glycoprotein
antigen
shift
result
reassort
variou
virus
swine
equin
human
varieti
contemporari
geograph
distribut
show
east
south
southeast
asia
influenc
unduli
evolut
season
influenza
export
evolutionarili
strain
ultim
spread
global
obviou
role
asia
evolut
ascrib
season
natur
influenza
temper
climat
season
influenza
acut
respiratori
ill
caus
influenza
b
virus
given
infect
includ
pandem
varieti
occur
part
world
discuss
detail
treatis
avian
influenza
virus
eg
emerg
rel
recent
caus
diseas
human
current
remain
potenti
threat
particularli
southeast
asia
first
associ
avian
influenza
clinic
respiratori
diseas
hong
kong
human
infect
transmit
bird
later
reemerg
human
highli
pathogen
viru
result
antigen
drift
larger
number
speci
vulner
confer
resist
adamantin
antivir
yet
human
human
transmiss
rare
vast
major
case
relat
contact
bird
travel
histori
recent
exposur
bird
affect
area
present
otherwis
unexplain
ard
screen
report
countri
current
preval
egypt
august
laboratori
confirm
case
influenza
patient
die
clinic
follow
exposur
incub
period
seven
day
less
clinic
characterist
includ
fever
respiratori
ill
pneumonia
diarrhoea
encephalopathi
laboratori
abnorm
may
includ
leukopenia
lymphopenia
thrombocytopenia
elev
serum
aminotransferas
complic
includ
multiorgan
failur
pulmonari
haemorrhag
pneumothorax
pancytopenia
radiograph
find
includ
diffus
patchi
infiltr
segment
lobar
consolid
progress
respiratori
failur
associ
diffus
bilater
groundglass
infiltr
diagnosi
comprehens
travel
epidemiolog
histori
critic
suspect
case
patient
meet
clinic
epidemiolog
criteria
test
avian
influenza
infect
diagnosi
establish
rrtpcr
viral
cultur
respiratori
specimen
serolog
test
help
acut
set
use
retrospect
diagnosi
introduct
anoth
avian
influenza
viru
deriv
reassort
least
four
avian
influenza
virus
caus
sever
pneumonia
patient
emerg
origin
eastern
china
addit
case
detect
mainland
china
hong
kong
macao
taiwan
malaysia
similar
viru
occur
primarili
bird
handler
follow
recent
exposur
live
poultri
potenti
contamin
environ
date
evid
sustain
humantohuman
transmiss
incub
period
estim
day
long
day
present
sign
symptom
may
includ
fever
cough
dyspnoea
headach
myalgia
malais
patient
present
lrti
may
progress
rapidli
pneumonia
potenti
acut
respiratori
failur
ard
septic
shock
multiorgan
failur
rhabdomyolysi
encephalopathi
sever
ill
fatal
outcom
frequent
observ
pregnant
women
older
person
chronic
ill
midaugust
total
laboratoryconfirm
case
report
includ
death
realtim
reversetranscriptas
polymeras
reaction
rrtpcr
avian
influenza
prefer
diagnost
test
sinc
rapid
antigen
test
may
insensit
novel
avian
influenza
strain
nasopharyng
swab
aspir
obtain
test
vaccin
best
method
protect
pandem
howev
avail
patient
contract
influenza
antivir
therapi
indic
certain
circumst
current
two
class
antivir
drug
avail
treatment
prevent
influenza
neuraminidas
inhibitor
oseltamivir
zanamivir
peramivir
adamantin
amantadin
rimantadin
adamantin
block
protein
channel
inhibit
uncoat
influenza
viru
enter
host
cell
activ
influenza
b
virus
due
mark
increas
resist
isol
mani
countri
recommend
use
except
combin
neuraminidas
inhibitor
select
case
therefor
adamantin
recommend
treatment
novel
influenza
viru
infect
neuraminidas
inhibitor
recommend
treat
patient
hospitalis
season
influenza
inclus
avian
influenza
infect
adult
dose
oseltamivir
mg
oral
twice
daili
inhal
zanamivir
mg
two
inhal
twice
daili
peramivir
mg
iv
daili
patient
sever
influenza
insuffici
data
recommend
use
inhal
zanamivir
iv
peramivir
empir
therapi
empir
treatment
oseltamivir
start
soon
possibl
hospitalis
case
associ
sever
diseas
confirm
probabl
outpati
case
earli
therapi
especi
within
h
ill
onset
shorten
durat
symptom
highrisk
patient
reduc
secondari
complic
associ
influenza
recommend
durat
antivir
therapi
five
day
uncompl
diseas
sever
ill
hospitalis
immunocompromis
patient
longer
cours
treatment
eg
day
consid
circumst
higher
dose
oseltamivir
recommend
expert
mg
twice
daili
adult
normal
renal
function
howev
oral
oseltamivir
report
adequ
absorb
critic
ill
patient
higher
dose
may
provid
addit
clinic
benefit
obes
patient
studi
demonstr
adequ
exposur
oseltamivir
carboxyl
activ
metabolit
oseltamivir
mg
twice
daili
dose
regimen
limit
data
suggest
oseltamivir
administ
oronasogastr
tube
well
absorb
critic
ill
patient
includ
continu
renal
replac
therapi
ecmo
patient
absorb
toler
oral
oseltamivir
use
iv
peramivir
investig
iv
zanamivir
consid
possibl
novel
influenza
virus
may
becom
resist
oseltamivir
peramivir
treatment
remain
suscept
zanamivir
resist
infect
zanamivir
prefer
agent
deliv
inhal
intraven
rout
corticosteroid
treatment
controversi
report
show
benefit
other
harm
case
sever
influenza
whatev
type
bacteri
coinfect
possibl
appropri
antimicrobi
treatment
direct
toward
organ
caus
bacteri
acut
commun
acquir
pneumonia
mechan
ventil
requir
reduc
mortal
rate
extracorpor
membran
oxygen
ecmo
utilis
patient
ard
one
studi
show
possibl
mortal
benefit
patient
refer
specialis
ecmo
centr
ongo
monitor
antivir
resist
among
avian
influenza
virus
crucial
evid
antivir
resist
report
highli
pathogen
avian
influenza
hpai
asian
virus
asian
virus
futur
treatment
strategi
may
make
use
new
gener
broadli
reactiv
monoclon
antibodi
addit
viral
rna
polymeras
inhibitor
favipiravir
regist
treatment
pandem
influenza
japan
potenti
lifethreaten
coronaviru
infect
caus
sever
acut
respiratori
syndrom
associ
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
case
sar
first
note
guangdong
provinc
china
novemb
ill
spread
countri
north
america
south
america
europ
asia
outbreak
contain
sarscov
novel
coronaviru
jump
speci
barrier
civet
man
base
upon
cluster
case
hong
kong
canada
sarscov
transmit
mean
close
persontoperson
contact
via
droplet
fomit
suggest
airborn
faecalor
transmiss
also
possibl
incub
period
two
seven
day
approxim
develop
symptom
day
follow
influenza
like
ili
prodrom
stage
high
fever
n
malais
headach
myalgia
chill
without
upper
respiratori
tract
symptom
patient
diarrhoea
prodrom
may
last
three
seven
day
involv
lrt
stage
occur
begin
nonproduct
cough
dyspnoea
may
progress
acut
hypoxaemia
radiolog
progress
pneumonia
patient
progress
stage
develop
featur
ard
may
requir
mechan
ventil
chest
radiograph
show
diffus
interstiti
infiltr
characterist
ard
risk
factor
poor
outcom
includ
older
age
underli
comorbid
diabet
atyp
symptom
elev
lactat
dehydrogenas
admiss
diagnosi
base
clinic
epidemiolog
laboratori
criteria
case
definit
develop
center
diseas
control
prevent
revers
transcriptas
polymeras
chain
reaction
rtpcr
serum
antibodi
measur
enzymelink
immunosorb
assay
elisa
test
two
reliabl
test
diagnosi
howev
serolog
test
acut
ill
limit
valu
sinc
antibodi
typic
develop
sever
week
ill
specif
treatment
recommend
except
support
care
benefit
otherwis
antivir
drug
glucocorticoid
establish
treatment
sar
mer
newli
recogn
highli
lethal
respiratori
ill
caus
merscov
merscov
zoonot
viru
studi
shown
human
infect
contact
infect
dromedari
camel
infect
peopl
diseas
first
report
saudi
arabia
june
far
case
link
travel
resid
countri
near
arabian
peninsula
outsid
arabian
peninsula
largest
known
outbreak
mer
occur
republ
korea
also
link
travel
return
arabian
peninsula
total
confirm
patient
merscov
infect
across
hospit
identifi
eightytwo
case
patient
expos
hospit
caregiv
hospit
staff
total
case
link
five
superspread
present
pneumonia
contact
hundr
peopl
sinc
although
countri
report
case
merscov
report
saudi
arabia
merscov
infect
anyon
patient
rang
age
year
old
incub
period
mer
usual
day
rang
day
patient
present
sever
acut
respiratori
ill
manifest
short
breath
preced
fever
cough
myalgia
arthralgia
rapid
progress
pneumonia
may
occur
within
first
week
often
requir
mechan
ventil
organ
support
renal
dialysi
patient
korean
outbreak
fever
chill
common
symptom
gastrointestin
symptom
includ
diarrhoea
nauseavomit
also
report
august
laboratoryconfirm
merscov
case
report
die
studi
shown
older
age
preexist
comorbid
import
risk
factor
death
mild
symptom
coldlik
symptom
symptom
usual
recov
case
definit
develop
center
diseas
control
prevent
usa
ministri
health
saudi
arabia
confirm
diagnosi
rrtpcr
perform
respiratori
secret
current
vaccin
prevent
merscov
infect
proven
antivir
therapi
manag
includ
prevent
daili
hygien
measur
travel
precaut
thereaft
symptomat
support
therapi
requir
hantaviru
member
bunyavirida
famili
genu
includ
n
differ
virus
manifest
wide
spectrum
clinic
ill
pathogenesi
hantaviru
relat
target
vascular
endotheli
cell
alveolar
macrophag
follicular
dendrit
cell
well
renal
tubular
epithelium
induct
vascular
capillari
leak
key
compon
pathogen
transmiss
human
via
contact
inhal
aerosolis
urin
saliva
faec
rodent
host
famili
murida
predomin
rural
diseas
risk
factor
includ
farm
land
develop
camp
howev
due
method
inocul
usual
acquir
indoor
person
person
transmiss
document
previous
subtyp
respiratori
precaut
recommend
health
care
worker
estim
case
hantaviru
occur
global
year
major
asia
caus
two
major
clinic
syndrom
name
hantaviru
pulmonari
syndrom
hp
haemorrhag
fever
renal
syndrom
hfr
former
occur
predomin
america
report
indic
increas
incid
hp
south
america
case
definit
hp
per
center
diseas
control
prevent
cdc
febril
ill
bilater
diffus
interstiti
edema
may
resembl
acut
respiratori
distress
syndrom
respiratori
compromis
requir
supplement
oxygen
develop
within
hour
hospitalis
previous
healthi
person
incub
period
two
three
week
follow
number
phase
includ
prodrom
nonspecif
viral
symptom
howev
also
thrombocytopenia
last
day
pulmonari
phase
symptom
respiratori
failur
predomin
progress
extrem
rapidli
h
shock
coagulopathi
pulmonari
oedema
bronchorrhea
arrhythmia
death
lastli
recoveri
phase
patient
often
period
signific
diuresi
endotheli
function
recov
fluid
redistribut
occur
urin
output
ml
per
hour
h
thereaft
convalesc
phase
prolong
week
month
hantaviru
diagnos
serolog
hantaviru
igm
posit
time
symptom
present
appropri
histori
exposur
obtain
presenc
thrombocytopenia
hemoconcentr
immunoblast
lack
toxic
granul
high
sensit
specif
hantaviru
chest
radiograph
abnorm
consist
interstiti
oedema
usual
present
admiss
worsen
respiratori
function
declin
advanc
respiratori
haemodynam
monitor
support
may
necessari
inclus
mechan
ventil
extracorpor
membran
oxygen
ecmo
often
challeng
lic
recommend
intraven
fluid
minimis
earli
institut
vasopressor
inotrop
support
aggress
fluid
resuscit
shown
increas
risk
respiratori
failur
unfortun
specif
antivir
therapi
demonstr
effect
burkholderia
pseudomallei
gram
neg
pathogen
endem
south
east
asia
northern
australia
india
south
china
taiwan
case
document
brazil
elsewher
south
america
papua
new
guinea
fiji
new
caledonia
despit
common
caus
fatal
commun
acquir
bacterem
pneumonia
north
east
thailand
darwin
seldom
recogn
import
area
endem
preval
vari
affect
region
may
relat
climact
condit
particularli
influenc
rainfal
reach
record
rate
case
per
peopl
heavier
usual
precipit
northern
australia
global
mortal
estim
extrem
high
similar
death
measl
much
higher
leptospirosi
dengu
infect
receiv
consider
attent
fact
mortal
may
even
higher
diagnosi
low
endem
area
primarili
due
low
resourc
set
occur
laboratori
facil
gener
poor
nonexist
infect
occur
inocul
contamin
soil
water
abras
ingest
inhal
subsequ
haematogen
spread
chronic
diseas
diabet
renal
failur
cystic
fibrosi
immunosuppress
agent
appear
suscept
infect
endem
area
asymptomat
signific
number
antibodi
histori
diseas
howev
least
case
present
pneumonia
vari
sever
rang
nodular
infiltr
septic
shock
mortal
lobar
consolid
present
less
florid
featur
former
often
littl
way
respiratori
symptom
present
fever
hypotens
organ
dysfunct
indol
form
may
mimic
tuberculosi
radiolog
commonli
involv
upper
lobe
howev
may
also
occur
lower
lobe
case
pleural
effus
empyema
may
occur
pulmonari
diffus
metastat
abscess
involv
spleen
kidney
prostat
liver
osteomyel
arthriti
may
also
occur
diagnosi
depend
obtain
posit
cultur
melioidosi
must
consid
differenti
febril
patient
visit
endem
region
antibiot
use
routin
commun
acquir
pneumonia
effect
inappropri
therapi
sever
diseas
increas
mortal
although
b
pseudomallei
grow
readili
laboratori
may
misidentifi
organ
pseudomona
may
lead
confus
potenti
incorrect
therapi
prior
avail
antibiogram
certain
specif
cultur
media
may
enhanc
growth
howev
alway
avail
outsid
endem
area
serolog
test
avail
posit
indirect
hemagglutin
test
iha
enzymelink
immunosorb
assay
elisa
travel
may
rais
suspicion
melioidosi
definit
diagnosi
base
cultur
posit
treatment
sever
diseas
administ
initi
intens
intraven
phase
combin
ceftazidim
meropenem
imipenem
cotrimoxazol
least
day
recommend
thailand
day
recommend
australia
thereaft
oral
erad
phase
consist
cotrimoxazol
amoxicillin
clavulan
administ
week
thailand
month
australia
yersinia
pesti
gram
neg
coccobacillu
notori
histor
caus
black
plagu
pesti
like
caus
three
major
pandem
led
signific
loss
life
first
centuri
ad
thought
region
popul
may
perish
accord
current
high
rate
plagu
democrat
republ
congo
madagascar
peru
diseas
three
clinic
syndrom
bubon
pneumon
septicaem
pneumon
plagu
lead
purul
exud
bronchopneumonia
usual
fatal
untreat
yersinios
zoonot
infect
human
accident
host
via
contact
infect
anim
usual
flea
vector
infect
acquir
via
bite
flea
scratch
bite
infect
anim
rodent
inhal
infect
respiratori
secret
infect
organ
carri
via
lymphat
local
lymph
node
follow
sever
inflammatori
reaction
case
plagu
report
death
case
africa
area
affect
plagu
includ
north
america
former
soviet
union
africa
asia
south
america
major
case
bubon
form
manifest
fever
chill
malais
dizzi
associ
lymphaden
caus
intens
pain
swell
lymph
node
region
untreat
dissemin
occur
lung
mening
case
caus
pneumonia
mening
septicaem
plagu
occur
without
bubon
ill
case
sever
ill
lead
profound
multiorgan
failur
pneumon
plagu
either
primari
secondari
former
develop
aerosol
exposur
pesti
symptom
develop
day
inocul
caus
person
person
spread
via
exposur
respiratori
droplet
caus
outbreak
extend
famili
secondari
pneumon
plagu
due
dissemin
pesti
lung
either
bubon
septicaem
phase
occur
approxim
patient
recent
data
suggest
pneumon
form
increas
incid
account
global
plagu
case
high
index
suspicion
import
order
make
diagnosi
confirm
serolog
cultur
recent
develop
rapid
diagnost
test
high
percentag
blood
cultur
posit
septicaem
plagu
gram
stain
cultur
sputum
lymph
node
aspir
usual
mean
diagnosi
demonstr
small
gram
neg
coccobacilli
mortal
rate
plagu
untreat
pneumon
plagu
mortal
untreat
treat
previous
streptomycin
prefer
antibiot
howev
case
gentamicin
prefer
altern
agent
includ
doxycyclin
tetracyclin
fluoroquinolon
prefer
agent
postexposur
prophylaxi
cap
usual
manag
accord
nation
guidelin
direct
toward
organ
seen
frequent
region
condit
describ
may
seen
frequent
part
world
may
treat
appropri
may
also
result
consider
spread
intensivist
awar
condit
make
sure
good
travel
histori
obtain
everi
case
